Visit | Screen. | Baseline | Random assignment by KKS | Intervention visits 1–12 | End of interÂvention | FU1 | FU2 | ||||||||||
Week | 0 | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 24 | 52 | |
Day | 0 | 1 | 7 | 14 | 21 | 28 | 35 | 42 | 49 | 56 | 63 | 70 | 77 | 84 | 168 | 364 | |
M.I.N.I. | D | ||||||||||||||||
Demographic data | D | ||||||||||||||||
GHQ-28 | P | P | P | P | |||||||||||||
PHQ-9 | P | P | P | P | |||||||||||||
ITQ | P | P | P | P | |||||||||||||
SSS-8 | P | P | P | P | |||||||||||||
Therapy expectations | P | ||||||||||||||||
EQ-5D | P | P | P | P | |||||||||||||
CSSRI | P | P | P | ||||||||||||||
CSSRI brief | P | ||||||||||||||||
PMLDC | P | P | P | P | |||||||||||||
ASCL/ArSCL | P | P | P | P | |||||||||||||
CSQ-8 | P | P | P | ||||||||||||||
TALQ | T | ||||||||||||||||
Diagnosis, meeting inclusion criteria | D | ||||||||||||||||
Informed consent | P | ||||||||||||||||
Adherence and competence rating | T | T | T | T | T | T | T | T | T | T | T | ||||||
TAU protocols | D | D | D | D |
ArSCL, Arab Symptom Checklist; ASCL, Afghan Symptom Checklist; CSQ-8, Client Satisfaction Questionnaire; CSSRI, Client Sociodemographic and Service Receipt Inventory; EQ-5D, EuroQol; FU, follow-up; GHQ-28, General Health Questionnaire; ITQ, International Trauma Questionnaire; M.I.N.I., Mini-International Neuropsychiatric Interview; PHQ-9, Patient Health Questionnaire; PMLDC, Post-Migration Living Difficulties Checklist; SSS-8, Somatic Symptom Scale; TALQ, Thinking a Lot Questionnaire; TAU, treatment as usual.